reports
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent, oral inhibitors with potential best-in-class profiles in RASm solid tumors Pipeline prioritization and workforce restructuring sharpens focus on programs targeting the highest unmet needs and with highest probability of success Priced concurrent $160 million equity offering Erasca to host conference call and webcast Friday, May 17, 2024 at 8:30 am ET SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-...
Erasca Announces Pricing of Underwritten Offering of Common Stock
Erasca Announces Pricing of Underwritten Offering of Common Stock SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten offering of 86,486,486 shares of its common stock at a price of $1.85 per share. All of the shares to be sold in the offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting dis...
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematolog...
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new and updated data related to novel investigational hematological malignancy therapies HMPL-306, HMPL-760 and tazemetostat, will be presented at the upcoming European Hematology Association (“EHA”) Hy...
ThreeD Capital Inc. Issues Early Warning Report in Connection With The...
ThreeD Capital Inc. Issues Early Warning Report in Connection With The Disposition of Securities of infinitii ai inc. TORONTO, May 16, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of recent transactions (“Dispositions”), ThreeD disposed of ownership and control of an aggregate of 5,159,000 common shares (the “Subject Shares”) of infinitii ai inc. (the “Company” or “infinitii”)...
Moody's Ratings assigns ratings to three classes of CLO refinancing no...
Moody's Ratings (Moody's) has assigned ratings to three classes of CLO refinancing notes (the "Refinancing Notes") issued by Generate CLO 5 Ltd. (the "Issuer"). Moody's rating action is as follows: U.S.$3,200,000 Class X-R Floating Rate Notes due 2037, Assigned Aaa (sf) U.S.$288,000,000 Class ...
Moody's Ratings changes Aramark's outlook to positive from stable; aff...
Moody's Ratings (Moody's) affirmed Aramark Services, Inc.'s ("Aramark") corporate family rating ("CFR") at Ba3, probability of default rating at Ba3-PD, and senior secured rating at Ba2. The senior unsecured rating was downgraded to B2 from B1. The Speculative Grade Liquidity ("SGL") rating was down...
Moody's Ratings revises outlook to positive for Advocate Health, Inc. ...
Moody's Ratings (Moody's) has revised the outlook to positive from stable for Advocate Aurora Health (WI), Atrium Health (legally known as Charlotte Mecklenburg Hospital Authority) (NC), and Wake Forest Baptist (NC), and affirmed the Aa3 ratings for Advocate Aurora Health and Atrium Health, and upgr...
Moody's Ratings assigns ratings to two classes of notes issued by Neub...
Moody's Ratings (Moody's) has assigned ratings to two classes of notes issued by Neuberger Berman Loan Advisers LaSalle Street Lending CLO II, Ltd. (the "Issuer" or "Neuberger Berman Loan Advisers LaSalle Street Lending CLO II"). Moody's rating action is as follows: U.S.$240,000,000 Class A-1 Se...
Moody's Ratings assigns A1 underlying/Aa3 enhanced to Batavia City Sch...
Moody's Ratings (Moody's) has assigned an A1 underlying rating and Aa3 enhanced rating to Batavia City School District, NY's approximately $12.98 million School District Serial Bonds, 2024. Moody's maintains an A1 rating on the district's outstanding general obligation unlimited tax (GOULT) bonds an...
Moody's Ratings assigns Aa3 und. & A1 enh. to Hardin County School Dis...
Moody's Ratings (Moody's) has assigned a Aa3 underlying rating and an A1 enhanced rating to Hardin County School District, Kentucky's $14.7 million Energy Conservation Revenue Bonds, Series of 2024, issued through the Hardin County School District Finance Corporation, KY. Moody's maintains the distr...
Terex Corp: 1 director
A director at Terex Corp sold 12,000 shares at 63.040USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Moody's Ratings assigns Ba1 rating to AES Corporation's new junior sub...
Moody's Ratings ("Moody's") assigned a Ba1 rating to The AES Corporation's (AES; Baa3 stable) $950 million junior subordinated notes due 2055 ("Notes") offering. The outlook of AES is stable. RATINGS RATIONALE The Ba1 assigned to the Notes is one notch below AES' Baa3 senior unsecured rating and...
Zai Lab Limited: 1 director
A director at Zai Lab Limited sold 10,000 shares at 21.335USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Salesforce Inc: 3 directors
Two Directors at Salesforce Inc sold after exercising options/sold 17,106 shares at between 280.000USD and 284.725USD. The significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all th...
Molson Coors Beverage Company Announces Regular Quarterly Dividend
GOLDEN, Colo. & MONTREAL--(BUSINESS WIRE)-- The Board of Directors of Molson Coors Beverage Company (NYSE: TAP, TAP.A) today declared a regular quarterly dividend on its Class A and Class B common stock of US$0.44 per share, payable June 21, 2024, to stockholders of record on June 7, 2024. The quarterly dividend is payable to holders of Class A and Class B common stock of Molson Coors Beverage Company. In addition, the Board of Directors of Molson Coors Canada Inc. (TSX: TPX.B, TPX.A) today declared a quarterly dividend of approximately CDN$0.59 (the Canadian dollar equivalent of the dividen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.